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A smoking cessation program in the neonatal intensive care unit
Abstract
Background: Parental smoking remains a significant risk to the preterm infant both pre and post delivery.
Pharmacologically supported interventions have been previously contraindicated in this group during the
perinatal period and during breastfeeding. We designed an evidence-based intervention for use in our
high-risk population. This report assesses our outcomes after one year. Method: Questionnaire
administered a median of 6 months after intervention. Results: There was no significant difference
between those participants who returned the survey (n = 42) versus the group as a whole (n = 70). A total
of 33% ceased smoking, p < .0001. If no nonresponders ceased smoking then this gives an overall
success rate of 20%, p < .0001. Successful quitters had been smoking for a mean of 11 (SD = 7) years.
Self-reported light smokers (< 10 cigarettes per day) were significantly more likely to quit (p < .01).
Purchase of follow-on nicotine patches was a significant predictor of success in quitting (p = .02). If
relapse occurred, it appeared to happen early and was mainly associated with current stressors.
Conclusions: We have designed and applied a multidisciplinary intervention for parents and carers to be
used in the perinatal period to decrease the postnatal risk for neonatal intensive care graduates. Our rates
of successful smoking cessation are as good as, or better than, many published rates for opportunistic
intervention. We suggest that randomised trials be focused on ways to further improve interventions at
this time of opportunity for these infants and their families.
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ackground: Parental smoking remains a significant risk to the preterm infant both pre and post
delivery. Pharmacologically supported interventions have been previously contraindicated in this
group during the perinatal period and during breastfeeding. We designed an evidence-based intervention for use in our high-risk population. This report assesses our outcomes after one year.
Method: Questionnaire administered a median of 6 months after intervention. Results: There was no
significant difference between those participants who returned the survey (n = 42) versus the group
as a whole (n = 70). A total of 33% ceased smoking, p < .0001. If no nonresponders ceased smoking
then this gives an overall success rate of 20%, p < .0001. Successful quitters had been smoking for
a mean of 11 (SD = 7) years. Self-reported light smokers (< 10 cigarettes per day) were significantly
more likely to quit (p < .01). Purchase of follow-on nicotine patches was a significant predictor of
success in quitting (p = .02). If relapse occurred, it appeared to happen early and was mainly associated with current stressors. Conclusions: We have designed and applied a multidisciplinary
intervention for parents and carers to be used in the perinatal period to decrease the postnatal risk
for neonatal intensive care graduates. Our rates of successful smoking cessation are as good as, or
better than, many published rates for opportunistic intervention. We suggest that randomised trials
be focused on ways to further improve interventions at this time of opportunity for these infants and
their families.
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In the most recent household survey undertaken in
Australia it was identified that approximately 22.9% of
women aged 20–29 years and 21.8% of women aged
30–39 years are current smokers of nicotine (Australian
Institute of Health and Welfare [AIHW], 2005), with
approximately 20% continuing to smoke during pregnancy (McDermott, Russell, & Dobson, 2002). These
rates vary between countries, with an estimated 12.6%
of pregnant women in the United States (Center for
Disease Control and Prevention [CDC], 2007) and 17%
of United Kingdom women continuing to smoke during
pregnancy (Information Centre, 2006). Smokers are
likely to be overrepresented in the mothers of infants
requiring neonatal intensive care (NICU), with the relative risk of admission to the NICU for these neonates

being increased by at least 20% compared to mothers
who do not smoke (Adams et al., 2002). Conversely, the
prevalence of smoking among mothers with premature
infants ranges between 34% and 49% (Elder et al., 1999;
Gennaro et al., 2001; Horta et al., 1997), but a significant
number of fathers also smoke (Horta et al., 1997), so
that the overall exposure of the NICU infant to environmental tobacco smoke from parents and carers may, in
our experience, be as high as 75%.
Environmental tobacco smoke remains a significant
risk for NICU graduates after leaving hospital, with
higher rates of neonatal morbidity and mortality (Aligne
& Stoddard, 1997; Cnattingius & Nordstrom, 1996;
DiFranza & Lew, 1996). Increased rates for both respiratory disorders (Aligne & Stoddard, 1997; DiFranza &
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Lew, 1996; Lodrup Carlsen & Carlsen, 2001) and sudden
infant death syndrome (SIDS; Aligne & Stoddard, 1997;
Klonoff-Cohen et al., 1995) have been found in those
neonates exposed to tobacco smoke both in utero and
postpartum. Access to tobacco increases the risk of nicotine toxicity and access to smoking paraphernalia
increases the risk of burns in young children (Aligne &
Stoddard, 1997; DiFranza & Lew, 1996). Children whose
carers smoke are also more likely to take up smoking
later in life (O’Callaghan et al., 2006), with all the associated health risks.
In view of these significant risks to the infants leaving
our NICU, we wished to find ways to reduce their rate
of smoking exposure. At the time of our intervention,
behavioural treatments were the recommended frontline treatment for nicotine dependence. Nicotine
replacement could be used in the event that behavioural
interventions were not successful. While only one form
of nicotine replacement, inhalers (Nicorette® Inhaler,
Pharmacia Pty Australia) was routinely approved for lactating women (New South Wales Health, 2002), inhalers
were more expensive than other forms of nicotine
replacement and only transdermal nicotine patches
(Nicobate® Patches, GlaxoSmithKline Consumer Healthcare, Australia) were available in our hospital formulary
at the time of our intervention.
The John Hunter NICU Smoking
Cessation Program
Smoking carers were identified by examining the antenatal history sheet, by questioning and by smell. We offered
smoking carers of NICU infants 2 weeks supply of
nicotine patches, with brief motivational counselling,
supply of written smoking cessation information (QUIT
kits, New South Wales [NSW] Department of Health,
Australia) and QUIT program registration (NSW Department of Health, Australia) — a telephone counselling
service to support smoking cessation. Motivational
counselling (Miller & Rollnick, 1991) was largely provided by one of the authors (SW) a neonatal Clinical
Nurse Consultant (CNC), supported by information,
advice and clinical supervision by Drug and Alcohol
staff (from within John Hunter Hospital). Nicotine
patches were prescribed by a neonatologist (14–21 milligram patches, dependent on smoking history), with
support from a pharmacist (KR), both of whom may
also have provided brief motivational counselling. The
CNC continued to follow up the family; either within
the NICU, by telephone or within the routine neonatal
outpatient clinic visits. Our aim in this study was to
assess the smoking cessation outcomes after running the
program for 12 months.
Method
A standardised questionnaire (available on request) was
mailed to 70 participants of the program, identified
from hospital records. Data was also collected in routine
74

neonatal outpatient clinic visits and telephone contact
was made for initial nonresponders.
Results were analysed using Instat (GraphPad, San
Diego, California). A probability of p < .05 was considered statistically significant. Proportions were analysed
using Fisher’s exact test. Proportion of successful cessation
was compared to an assumed cessation rate of zero.
Continuous data was described using medians or means
depending on the normality of the data. Normally distributed continuous data was compared with unpaired t tests.
Results
Questionnaires were returned from 42 (60%) respondents. The characteristics of those returning the survey
appeared to be representative of the group as a whole:
there was no significant difference between those participants who returned the survey versus the group as a
whole with regards to gender (61.9% vs. 62.9%) or
transdermal nicotine dose prescribed (73.8% received 21
mg/24 hr. vs. 78.6% 21 mg/24 hr). Although survey
return rate was lower from the early part of the program
compared to later (51% vs. 78%), this did not reach statistical significance.
At a median time of 6½ months after transdermal
nicotine patch use (range 3–9 months) 14 (33%) of
the respondents were not smoking (95% CI: 25–44%,
p < .0001, compared to zero cessation). If it is assumed
that none of the nonresponders ceased smoking then
there was an overall success rate of 20% (95% CI:
16–24%, p < .0001, compared to no cessation).
Further analysis of associated factors could only be
undertaken in those who returned a questionnaire.
Successful use of the quitting program was not associated with sex of the smoker, dose received or whether
the program was commenced in hospital or at home.
Continuing smokers had been smoking for a mean of 13
years (SD = 7 years) compared to 11 years for successful
quitters (SD = 7years). This was not statistically different. Self-reported light smokers (<10 cigarettes per day)
were significantly more likely to quit than those admitting to greater use (p < .01).
Twenty-eight respondents remembered getting an
information leaflet (67%); there was no statistical difference in this between successful quitters and those who
were unsuccessful. A total of 75% of those responding
thought the information was useful, but only one third
of these gave up. Staff members recalled as providing
advice were: neonatal nurse (90%), neonatologist (50%)
and neonatal pharmacist (43%). Most felt that this was
helpful (87%, 71% and 72% respectively) but a positive
response was not associated with successful quitting.
Only 40% said that they had purchased the followup patches after the initial 2 weeks supply. A total of
64% of those who quit long term bought the follow-on
patches compared to 25% of those who continued to
JOURNAL OF SMOKING CESSATION
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Figure 1
Factors stated as being involved in restarting or continuing smoking, n = 42
(more than one factor may have been nominated by each individual).

smoke. Purchase of follow-on patches was a significant
predictor of success in quitting (p = .02).
Twenty-nine respondents (69%) quit initially, but 15
of these restarted; giving a relapse rate of 52%. Median
time to relapse was 3 weeks, with a range of 0.5–12
weeks after the program started. Factors cited in restarting or continuing smoking are shown in Figure 1.
Although we have not assessed formally beyond the
initial review, these families of sick infants are usually
followed for at least the first year of life. During that time
we are not aware of any of the initial successful quitters
who have restarted smoking. Two further smokers, who
failed to quit originally, have since ceased smoking, one
with support alone and the other with a repeat transdermal nicotine patch program.
Discussion
Several studies and Cochrane reviews have been performed investigating interventions for smoking
behaviours in settings similar to ours with mixed findings (Hollis et al., 1993; Lancaster and Stead, 2005;
Lumley et al., 2004; Rice and Stead, 2006; Rigotti et al.,
2002; Woodward et al., 1987; Valanis et al., 2001). Small,
but significant increases in cessation have been found for
brief physician advice (Lancaster & Stead, 2004), with
increased benefit from intensive intervention over
minimal advice. Nursing interventions have also been
shown to improve the odds for quitting (Rice & Stead,
2006). Intensive interventions for hospital inpatients are
also successful in improving cessation rates (Rigotti et
al., 2002). Importantly, none of these studies were
specifically in the NICU setting. Our success rates at
least equal, and exceed many of, the published rates for
opportunist intervention (Hollis et al., 1993; Lumley et
al., 2004; Woodward et al., 1987; Valanis et al., 2001).
Provision of nicotine replacement treatment was not
necessarily a feature of all unsuccessful interventions,
indicating that use of nicotine replacement is an imporJOURNAL OF SMOKING CESSATION

tant component of clinical practice. Participants of most
opportunistic nicotine cessation research tend to be targeted as a result of their own health status. We have
attempted to obtain empathic engagement with the
smoker through a joint concern for the neonate admitted to the NICU. It is our belief that this may provide the
‘window of opportunity’ often cited in the drug and
alcohol treatment literature (Miller & Rollnick, 1991).
Our findings further demonstrate that the NICU can
actively support smoking cessation as being a powerful
force to influence the motivation to change.
A major limitation of this study was the reliance
upon self-report of smoking status. Self-report has,
however, been found to be a valid means of assessing
smoking status (Patrick et al., 1994). Objective measures,
such as cotinine or carboxyhaemoglobin, can be useful,
but are expensive and time consuming. This was not a
randomised controlled trial and our assumption of a
negligible cessation rate without intervention may be
invalid. In our experience, however, those that smoke
throughout pregnancy are unlikely to quit after the birth
of a baby and this has been found by others (Woodward
et al., 1987, Valanis et al., 2001).
Our findings demonstrate that a smoke-free environment can be an aim for our NICU graduates, using
evidence-based interventions. Efforts to encourage
smoking cessation antenatally should continue but, in
addition, the application of smoking cessation strategies
for all smoking carers of neonates admitted to the NICU
should be a routine component of postpartum care. We
suggest that randomised trials be focused on ways to
further improve interventions at this time of opportunity for these infants and their families.
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